Federated Hermes
ACH

Federated Hermes’s Accendra Health ACH Stock Holding History

Federated Hermes’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-428,598
Closed -$3.87M – 2158
2025
Q1 		$3.87M Buy
+428,598
New +$4.53M 0.01% 776
2024
Q4 		– Sell
-2,312
Closed -$36.3K – 2160
2024
Q3 		$36.3K Sell
2,312
-10,761
-82% -$163K ﹤0.01% 1702
2024
Q2 		$176K Sell
13,073
-154,918
-92% -$3.17M ﹤0.01% 1501
2024
Q1 		$4.66M Sell
167,991
-4,845
-3% -$108K 0.01% 744
2023
Q4 		$3.33M Sell
172,836
-226,247
-57% -$4.1M 0.01% 818
2023
Q3 		$6.45M Buy
399,083
+65,757
+20% +$1.17M 0.02% 636
2023
Q2 		$6.35M Buy
333,326
+154,868
+87% +$2.76M 0.02% 647
2023
Q1 		$2.6M Buy
178,458
+176,791
+10,605% +$3.17M 0.01% 871
2022
Q4 		$32.6K Buy
1,667
+484
+41% +$9.44K ﹤0.01% 1759
2022
Q3 		$29K Buy
1,183
+180
+18% +$5.55K ﹤0.01% 1739
2022
Q2 		$32K Sell
1,003
-42,798
-98% -$1.55M ﹤0.01% 1720
2022
Q1 		$1.93M Sell
43,801
-148,304
-77% -$6.37M ﹤0.01% 1051
2021
Q4 		$8.36M Buy
192,105
+31,702
+20% +$1.24M 0.02% 700
2021
Q3 		$5.02M Buy
160,403
+120,445
+301% +$4.74M 0.01% 822
2021
Q2 		$1.69M Buy
39,958
+2,200
+6% +$85.6K ﹤0.01% 1144
2021
Q1 		$1.42M Buy
37,758
+12,960
+52% +$405K ﹤0.01% 1243
2020
Q4 		$670K Buy
24,798
+10,849
+78% +$279K ﹤0.01% 1452
2020
Q3 		$350K Buy
+13,949
New +$203K ﹤0.01% 1564
2020
Q2 		– Sell
-408
Closed -$4K – 2339
2020
Q1 		$4K Sell
408
-149,008
-100% -$899K ﹤0.01% 1948
2019
Q4 		$772K Buy
149,416
+148,740
+22,003% +$955K ﹤0.01% 1335
2019
Q3 		$4K Buy
+676
New +$3.03K ﹤0.01% 1973
2018
Q1 		– Sell
-5,944
Closed -$112K – 2214
2017
Q4 		$112K Sell
5,944
-204,400
-97% -$4.53M ﹤0.01% 1583
2017
Q3 		$6.14M Buy
210,344
+6,259
+3% +$185K 0.02% 503
2017
Q2 		$6.57M Sell
204,085
-59,575
-23% -$1.96M 0.02% 502
2017
Q1 		$9.12M Sell
263,660
-19,394
-7% -$693K 0.03% 434
2016
Q4 		$9.99M Sell
283,054
-72,814
-20% -$2.46M 0.03% 410
2016
Q3 		$12.4M Sell
355,868
-74,372
-17% -$2.6M 0.04% 381
2016
Q2 		$16.1M Sell
430,240
-15,603
-3% -$586K 0.05% 317
2016
Q1 		$18M Buy
445,843
+38,240
+9% +$1.42M 0.06% 286
2015
Q4 		$14.7M Buy
407,603
+67,755
+20% +$2.45M 0.05% 349
2015
Q3 		$10.9M Buy
339,848
+87,342
+35% +$2.97M 0.04% 420
2015
Q2 		$8.59M Sell
252,506
-35,072
-12% -$1.18M 0.03% 493
2015
Q1 		$9.73M Buy
287,578
+57,450
+25% +$2M 0.03% 464
2014
Q4 		$8.08M Buy
230,128
+177,167
+335% +$5.97M 0.03% 501
2014
Q3 		$1.73M Buy
52,961
+269
+0.5% +$9.15K 0.01% 1019
2014
Q2 		$1.79M Sell
52,692
-2,105
-4% -$72.1K 0.01% 998
2014
Q1 		$1.92M Sell
54,797
-10,502
-16% -$371K 0.01% 965
2013
Q4 		$2.39M Sell
65,299
-1,552
-2% -$57K 0.01% 866
2013
Q3 		$2.31M Sell
66,851
-3,183
-5% -$111K 0.01% 844
2013
Q2 		$2.37M Buy
+70,034
New +$2.32M 0.01% 827

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Federated Hermes's ACH Position: Q2 2025 in Review

Federated Hermes sold out of Accendra Health (ACH) in Q2 2025, closing a stake of 428,598 shares — an estimated $3.87M sold.

Federated Hermes first reported a position in ACH in Q2 2013 and held it in 40 quarters. The position peaked at $18M in Q1 2016. 234 funds tracked by Wall St. Rank hold ACH as of Q2 2025.

  • Federated Hermes reported no remaining Accendra Health position as of Q2 2025 after selling out during the quarter.
  • Federated Hermes sold 428,598 Accendra Health shares in Q2 2025, an estimated $3.87M.
  • Federated Hermes first reported a position in Accendra Health in Q2 2013 and held it in 40 quarters.
  • Federated Hermes's Accendra Health position peaked at $18M in Q1 2016.
  • 234 funds tracked by Wall St. Rank held Accendra Health as of Q2 2025.

Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.